Zhendong Pharmacy released its 2024 annual performance, with a net loss attributable to the parent company of 1.329 billion yuan
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Zhendong Pharmacy released its annual report for 2024. During the reporting period, the company achieved operating revenue of 2.971 billion yuan, a year-on-year decrease of 18.06%. The net loss attributable to shareholders of the listed company was 1.329 billion yuan, and the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 686 million yuan, with a basic loss per share of 1.2977 yuan
According to the Zhitong Finance APP, Zhendong Pharmacy (300158.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 2.971 billion yuan, a year-on-year decrease of 18.06%. The net loss attributable to shareholders of the listed company was 1.329 billion yuan, and the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 686 million yuan, with a basic loss per share of 1.2977 yuan